Carter's
CRI
32.45
-1.38
-4.08%
Carter's
US · CRI
#3137 by market cap
32.45
-1.38
-4.08%
Live - 5344 symbols - heartbeat 525s ago
· 2026-10-07 20:02
After-hours
32.45
0.00%
- Market cap
- 1.19B
- P/E (TTM)i
- 6.05
- P/Bi
- 1.16
- EPSi
- 2.53
- Div yieldi
- 3.08%
- 52W posi
- 33%
Reader sentiment
Are you bullish or bearish on CRI?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Fair
- Altman Z-Score is 2.62, in the 1.8-3.0 "grey zone".
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year +1.91% YoY
Margins
- Gross margin
- 45.36%
- Operating margin
- 4.97%
- Net margin
- 3.09%
Key ratios & quality
- Enterprise valuei
- 1.39B
- Altman Z-Scorei
- 2.62
Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2018 | 2019 | 2021 | 2021 | 2022 | 2023 | 2024 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 3.46B | 3.52B | 3.02B | 3.49B | 3.21B | 2.95B | 2.84B | 2.90B |
| Gross profit | 1.50B | 1.51B | 1.31B | 1.66B | 1.47B | 1.40B | 1.37B | 1.31B |
| Selling & admin expenses | 1.14B | 1.14B | 1.11B | 1.19B | 1.11B | 1.09B | 1.10B | 1.19B |
| Research & development | -- | -- | -- | -- | -- | -- | -- | -- |
| Operating profit | 391.43M | 402.67M | 234.11M | 497.08M | 388.17M | 323.41M | 284.73M | 143.93M |
| Pretax profit | 355.98M | 327.95M | 134.98M | 438.29M | 316.74M | 302.24M | 230.81M | 113.83M |
| Tax | 73.91M | 64.15M | 25.27M | 98.54M | 66.70M | 69.74M | 45.30M | 22.04M |
| Net profit | 282.07M | 263.80M | 109.72M | 339.75M | 250.04M | 232.50M | 185.51M | 91.80M |
| Basic EPS | 6 | 6 | 3 | 8 | 6 | 6 | 5 | 3 |
| Diluted EPS | 6.00 | 5.85 | 2.50 | 7.81 | 6.34 | 6.24 | 5.12 | 2.53 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2026-01 | 2026-04 | 2026-07 |
|---|---|---|---|---|---|---|
| Revenue | 629.83M | 585.31M | 757.84M | 925.45M | 681.11M | 615.49M |
| Gross profit | 291.09M | 281.76M | 341.63M | 400.16M | 293.87M | 412.60M |
| Selling & admin expenses | 270.32M | 280.97M | 317.96M | 319.56M | 270.05M | 276.14M |
| Research & development | -- | -- | -- | -- | -- | -- |
| Operating profit | 26.10M | 4.04M | 29.09M | 84.69M | 28.44M | 139.83M |
| Pretax profit | 21.35M | 1.70M | 14.83M | 75.95M | 19.86M | 136.65M |
| Tax | 5.81M | 1.26M | 3.24M | 11.73M | 5.52M | 31.69M |
| Net profit | 15.54M | 446.00K | 11.59M | 64.22M | 14.34M | 104.96M |
| Basic EPS | 0 | 0 | 0 | 2 | 0 | 3 |
| Diluted EPS | 0.43 | 0.01 | 0.32 | 1.76 | 0.39 | 2.87 |
Balance sheet
| Line item | 2018 | 2019 | 2021 | 2021 | 2022 | 2023 | 2024 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 1.04B | 1.11B | 1.95B | 1.90B | 1.19B | 1.10B | 1.14B | 1.27B |
| Cash & ST investments | 170.08M | 214.31M | 1.10B | 984.29M | 211.75M | 351.21M | 412.93M | 508.81M |
| Inventory | 574.23M | 593.99M | 599.26M | 647.74M | 744.57M | 537.13M | 502.33M | 544.62M |
| Total assets | 2.06B | 2.75B | 3.39B | 3.19B | 2.44B | 2.38B | 2.43B | 2.57B |
| Total current liabilities | 327.42M | 475.50M | 792.53M | 717.23M | 528.95M | 511.86M | 508.82M | 506.00M |
| Short-term debt | -- | 160.23M | 185.15M | 133.74M | 142.43M | 135.37M | 130.56M | 136.49M |
| Long-term debt | 593.26M | 594.67M | 989.53M | 991.37M | 616.62M | 497.35M | 498.13M | 567.17M |
| Total liabilities | 1,189,425,000.00 | 1,872,987,000.00 | 2,454,547,000.00 | 2,237,812,000.00 | 1,643,306,000.00 | 1,533,363,000.00 | 1,578,605,000.00 | 1,640,422,000.00 |
| Total equity | 869.43M | 880.13M | 938.03M | 950.19M | 796.41M | 845.25M | 854.56M | 925.05M |
| Retained earnings | 909.82M | 915.32M | 952.60M | 978.67M | 830.37M | 868.80M | 894.02M | 929.46M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2026-01 | 2026-04 | 2026-07 |
|---|---|---|---|---|---|---|
| Total current assets | 1.05B | 1.16B | 1.13B | 1.27B | 1.21B | 1.47B |
| Cash & ST investments | 320.79M | 338.18M | 184.19M | 508.81M | 473.44M | 653.57M |
| Inventory | 474.12M | 619.07M | 656.15M | 544.62M | 465.88M | 577.74M |
| Total assets | 2.33B | 2.46B | 2.47B | 2.57B | 2.48B | 2.73B |
| Total current liabilities | 409.35M | 525.67M | 501.69M | 506.00M | 433.43M | 596.22M |
| Short-term debt | 125.56M | 124.00M | 150.55M | 136.49M | 133.38M | 132.72M |
| Long-term debt | 498.33M | 498.53M | 498.74M | 567.17M | 567.49M | 567.81M |
| Total liabilities | 1,484,555,000.00 | 1,601,650,000.00 | 1,604,797,000.00 | 1,640,422,000.00 | 1,555,698,000.00 | 1,705,037,000.00 |
| Total equity | 847.25M | 853.90M | 864.64M | 925.05M | 928.46M | 1.03B |
| Retained earnings | 880.56M | 871.89M | 874.36M | 929.46M | 934.58M | 1.03B |
Cash flow
| Line item | 2018 | 2019 | 2021 | 2021 | 2022 | 2023 | 2024 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 356.20M | 387.22M | 588.49M | 268.26M | 88.36M | 529.13M | 298.79M | 122.33M |
| Depreciation & amortization | 89.65M | 95.95M | 94.00M | 94.11M | 65.28M | 64.14M | 57.93M | 55.26M |
| Free cash flow | 292.42M | 325.80M | 555.62M | 230.82M | 48.00M | 469.27M | 242.62M | 68.63M |
| Dividends paid | -83.72M | -89.59M | -26.26M | -60.12M | -118.11M | -112.01M | -116.18M | -56.36M |
| Stock buybacks / issuance | -193.03M | -196.91M | -45.26M | -299.34M | -299.67M | -100.03M | -50.53M | 0 |
| Ending cash balance | 170.08M | 214.31M | 1.10B | 984.29M | 211.75M | 351.21M | 412.93M | 487.08M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2026-01 | 2026-04 | 2026-07 |
|---|---|---|---|---|---|---|
| Operating cash flow | -48.64M | 40.31M | -127.97M | 258.64M | 6.42M | 195.88M |
| Depreciation & amortization | 13.25M | 13.56M | 13.77M | 14.69M | 13.63M | 13.02M |
| Free cash flow | -58.99M | 24.11M | -144.09M | 247.60M | -543.00K | 190.04M |
| Dividends paid | -29.00M | -9.12M | -9.13M | -9.11M | -9.22M | -9.13M |
| Stock buybacks / issuance | -- | -- | -- | 0 | -- | -- |
| Ending cash balance | 320.79M | 338.18M | 184.19M | 487.08M | 473.44M | 653.57M |
Returns & efficiency
| Line item | 2018 | 2019 | 2021 | 2021 | 2022 | 2023 | 2024 | 2026 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | 32.43 | 29.88 | 11.95 | 35.55 | 28.21 | 27.80 | 21.39 | 10.06 |
| ROA %i | 13.57 | 10.86 | 3.53 | 10.18 | 8.73 | 9.47 | 7.56 | 3.58 |
| ROIC %i | 20.90 | 14.82 | 6.16 | 14.68 | 12.38 | 12.84 | 10.13 | 5.15 |
| 5-year avg ROE %i | 30.77 | 31.58 | 28.30 | 29.26 | 27.60 | 26.68 | 24.98 | 24.60 |
| EBIT margin %i | 11.28 | 10.39 | 6.32 | 14.30 | 11.19 | 11.41 | 9.22 | 5.11 |
| FCF / sales %i | 8.45 | 9.26 | 18.42 | 6.62 | 1.49 | 15.93 | 8.53 | 2.37 |
| Current ratioi | 3.19 | 2.33 | 2.46 | 2.65 | 2.25 | 2.15 | 2.25 | 2.51 |
| Quick ratioi | 1.31 | 0.98 | 1.63 | 1.69 | 0.78 | 1.05 | 1.19 | 1.36 |
| Debt / assetsi | 28.82 | 51.55 | 50.97 | 49.15 | 48.40 | 45.47 | 46.45 | 47.25 |
| LT debt / equityi | 68.24 | 143.05 | 164.60 | 150.84 | 130.38 | 111.94 | 116.98 | 116.28 |
| Interest coveragei | 11.30 | 9.72 | 3.41 | 8.27 | 8.40 | 9.90 | 8.37 | 4.33 |
| Revenue CAGR (3Y) %i | 4.73 | 3.24 | -3.83 | 0.23 | -2.99 | -0.88 | -6.56 | -3.37 |
| Net income CAGR (3Y) %i | 5.85 | 0.78 | -28.71 | 6.40 | -1.77 | 28.44 | -18.27 | -28.40 |
| FCF CAGR (3Y) %i | 12.66 | 5.09 | 28.78 | -7.58 | -47.19 | -5.47 | 1.68 | 12.66 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2026-01 | 2026-04 | 2026-07 |
|---|---|---|---|---|---|---|
| ROE %i | 18.92 | 15.91 | 10.24 | 10.06 | 9.93 | 20.24 |
| ROA %i | 6.92 | 5.51 | 3.58 | 3.58 | 3.66 | 7.34 |
| ROIC %i | 9.06 | 7.67 | 5.08 | 5.15 | 5.28 | 9.98 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 8.30 | 7.09 | 5.11 | 5.11 | 5.10 | 9.70 |
| FCF / sales %i | 7.87 | 4.95 | 3.25 | 2.37 | 4.31 | 9.83 |
| Current ratioi | 2.56 | 2.20 | 2.26 | 2.51 | 2.80 | 2.47 |
| Quick ratioi | 1.28 | 0.91 | 0.84 | 1.36 | 1.55 | 1.38 |
| Debt / assetsi | 48.14 | 45.79 | 47.72 | 47.25 | 48.16 | 43.36 |
| LT debt / equityi | 117.67 | 117.15 | 118.88 | 116.28 | 114.48 | 102.41 |
| Interest coveragei | 7.47 | 6.43 | 4.66 | 4.33 | 3.94 | 6.94 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
✦ Quant Revenue Concentration how this is computed
Lead segment, long tail
- U.S. Retail is the largest reported line at 49.50% of revenue, across 3 reported segments.
- U.S. Wholesale follows at 35.02%, so the top line still matters most but isn’t the whole story.
Revenue breakdown most recent period
Business
U.S. Retail49.50%
U.S. Wholesale35.02%
International15.48%
Quote time 2026-10-07 20:02:36 · For reference only, not investment advice and not tailored to your situation.